ANDREA PAGUIRIGAN: Open Payments
NPI 1881809085 · CANAL WINCHESTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 37 payments from 16 companies in 2025. Trend: 2023 $509 · 2024 $586 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $154 |
| ABBVIE INC. | 5 | $103 |
| Novo Nordisk Inc | 5 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
| SANOFI-AVENTIS U.S. LLC | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Lilly USA, LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Astellas Pharma US Inc | 1 | $22 |
Products named: UBRELVY, Ozempic, XIFAXAN, TZIELD, NURTEC ODT, Wegovy, MOUNJARO, PAXLOVID.
Industry payments across OH — which companies pay providers there.
